Phospho-HDAC7 (Ser155) Antibody

What is Phospho-HDAC7 (Ser155) Antibody and what does it specifically detect?

Phospho-HDAC7 (Ser155) antibody is a rabbit polyclonal antibody specifically designed to detect endogenous levels of HDAC7A (Histone Deacetylase 7A) protein only when phosphorylated at serine 155 . This antibody recognizes the phosphorylated form of HDAC7 with high specificity and does not cross-react with the non-phosphorylated form of the protein . The antibody is typically generated by immunizing rabbits with synthetic phosphopeptides derived from human HDAC7A around the phosphorylation site of Ser155, followed by affinity purification using epitope-specific phosphopeptides . Non-phospho specific antibodies are removed through chromatography using non-phosphopeptides to ensure specificity .

What is the molecular basis for the specificity of Phospho-HDAC7 (Ser155) antibodies?

The specificity of these antibodies stems from their ability to recognize the unique three-dimensional conformation created by the phosphate group at Ser155 within the specific amino acid sequence context of HDAC7. Commercial antibodies are typically raised against synthetic phosphopeptides containing the target sequence T-V-S(p)-E-P derived from human HDAC7A . The immunizing phosphopeptides usually span the region around Ser155, typically amino acids 121-170 of human HDAC7A . This targeted approach allows the antibody to discriminate between phosphorylated and non-phosphorylated states of the same protein, making it a valuable tool for studying dynamic phosphorylation events .

What is the correspondence between human and mouse HDAC7 phosphorylation sites?

It's important for researchers to note the species-specific numbering of phosphorylation sites. The Ser155 position in human HDAC7 corresponds to Ser178 in mouse HDAC7 . This distinction is critical when designing experiments, interpreting literature, and selecting appropriate antibodies. The phosphopeptides used to generate antibodies against mouse HDAC7 phosphorylated at Ser178 typically use the sequence FPLRTV[pSer]EPNLKL . When working across species, researchers should carefully verify the conservation of the phosphorylation site and surrounding sequences to ensure proper antibody reactivity .

What are the validated applications for Phospho-HDAC7 (Ser155) antibodies?

Phospho-HDAC7 (Ser155) antibodies have been validated for several experimental applications:

The antibody has been most extensively validated for Western blotting applications, where it can detect the phosphorylated form of HDAC7 at approximately 102-105 kDa . When designing experiments, researchers should perform preliminary titration experiments to determine the optimal dilution for their specific experimental conditions and cell types .

How should phospho-HDAC7 antibodies be validated for experimental use?

Proper validation of phospho-specific antibodies should include multiple approaches:

• Phosphatase treatment control: Treat immunoprecipitated HDAC7 with phosphatase enzymes to abolish the reactivity of the phospho-specific antibody, confirming its specificity for the phosphorylated form .

• Stimulation experiments: Compare signal intensity in unstimulated versus stimulated conditions known to induce HDAC7 phosphorylation, such as PMA treatment or TCR activation via CD3 cross-linking in T cells .

• Mutational analysis: Compare antibody reactivity between wild-type HDAC7 and mutants where the target serine is substituted with alanine (e.g., S155A) .

• Peptide competition: Pre-incubate the antibody with the phosphopeptide used as immunogen to compete away specific binding .

• Cross-reactivity assessment: Test the antibody against related phosphorylation sites in other class IIa HDACs to ensure specificity .

These validation steps are critical for confirming antibody specificity and avoiding misinterpretation of experimental results .

What are the optimal storage and handling conditions for maintaining antibody efficacy?

To maintain the efficacy of Phospho-HDAC7 (Ser155) antibodies:

Most manufacturers ship these antibodies at 4°C, but upon delivery, they should be immediately aliquoted and stored at -20°C for optimal long-term stability . The typical shelf life at -20°C is approximately one year from the date of receipt .

What is the biological significance of HDAC7 phosphorylation at Ser155?

Phosphorylation of HDAC7 at Ser155 plays a crucial regulatory role in cellular processes:

• Nucleocytoplasmic shuttling: Phosphorylation at Ser155 is a key event that triggers the nuclear export of HDAC7, relocating it from the nucleus to the cytoplasm . This translocation is mediated by the binding of 14-3-3 proteins to the phosphorylated residue .

• Transcriptional regulation: In the nucleus, HDAC7 functions as a transcriptional repressor. Its phosphorylation-induced export to the cytoplasm leads to derepression of target genes like Nur77 in thymocytes .

• T-cell signaling: In CD4⁺CD8⁺ double-positive thymocytes, HDAC7 phosphorylation occurs following T-cell receptor (TCR) activation, serving as a critical step in T-cell development and selection .

• Apoptotic regulation: The nuclear export of HDAC7 following phosphorylation can lead to the derepression of genes involved in apoptosis, such as Nur77, influencing cell survival decisions .

The phosphorylation status of HDAC7 at Ser155 thus represents a molecular switch that controls its subcellular localization and repressive function .

What kinases and phosphatases regulate HDAC7 Ser155 phosphorylation?

The phosphorylation state of HDAC7 at Ser155 is dynamically regulated by specific kinases and phosphatases:

This dynamic regulation creates a molecular switch mechanism where kinases like PKD1 promote nuclear export through phosphorylation, while phosphatases like PP1β and PP2A promote nuclear retention through dephosphorylation . The balance between these opposing enzymatic activities determines HDAC7 localization and function in response to cellular signals .

How does 14-3-3 protein binding affect HDAC7 phosphorylation status?

14-3-3 proteins play a crucial role in protecting phosphorylated HDAC7 from dephosphorylation:

• Binding specificity: 14-3-3 proteins specifically bind to phosphorylated serine residues within HDAC7, including Ser155, recognizing the phosphoserine in context with surrounding amino acids .

• Protection from phosphatases: When bound to phosphorylated Ser155, 14-3-3 proteins physically block access of phosphatases like PP2A, preventing dephosphorylation . In vitro experiments have shown that addition of GST-14-3-3ζ completely prevents HDAC7 dephosphorylation by PP2A .

• Stabilization of phosphorylation: The proline residue at position +2 relative to Ser155 (Pro157) is crucial for 14-3-3 recognition. Mutation of Pro157 to alanine (P157A) disrupts 14-3-3 binding and results in complete loss of Ser155 phosphorylation in vivo due to increased susceptibility to dephosphorylation .

• Hierarchical phosphorylation: The protection of Ser155 by 14-3-3 also influences phosphorylation at other sites, as demonstrated by the reduced phosphorylation at Ser181 observed in the P157A HDAC7 mutant .

This protective mechanism creates a feed-forward loop where initial phosphorylation leads to 14-3-3 binding, which maintains the phosphorylated state by preventing access by phosphatases .

How can Phospho-HDAC7 (Ser155) antibodies be used to study dynamic phosphorylation events?

Researchers can use these antibodies to investigate dynamic phosphorylation events through several sophisticated approaches:

• Time-course experiments: Following stimulation (e.g., PMA treatment or TCR activation), researchers can collect samples at various time points to track the kinetics of HDAC7 phosphorylation using Western blotting with phospho-specific antibodies .

• Phosphatase inhibitor studies: Treating cells with phosphatase inhibitors like okadaic acid (OA) can reveal the dynamic balance between kinase and phosphatase activities regulating HDAC7 phosphorylation status .

• Subcellular fractionation: Combining phospho-specific detection with nuclear/cytoplasmic fractionation allows researchers to correlate phosphorylation status with subcellular localization .

• Live-cell imaging: For advanced applications, GFP-tagged HDAC7 constructs can be used in conjunction with indirect immunofluorescence using phospho-specific antibodies to visualize the spatiotemporal dynamics of HDAC7 phosphorylation and translocation .

• Mass spectrometry validation: Phospho-specific antibodies can be used to enrich phosphorylated HDAC7 for subsequent mass spectrometry analysis to confirm phosphorylation sites and identify novel modifications .

These approaches provide complementary information about the regulation of HDAC7 phosphorylation in diverse biological contexts .

What experimental strategies can distinguish between different phosphorylated forms of HDAC7?

HDAC7 contains multiple phosphorylation sites, requiring strategies to distinguish between them:

• Parallel analysis with site-specific antibodies: Using a panel of phospho-specific antibodies targeting different sites (e.g., Ser155, Ser181, Ser321, Ser449, Ser486) in parallel Western blots can reveal site-specific phosphorylation patterns .

• Phosphopeptide mapping: After immunoprecipitation of HDAC7 from [32P]-labeled cells, two-dimensional phosphopeptide mapping can distinguish between different phosphorylated residues .

• HPLC analysis of tryptic phosphopeptides: This approach can quantitatively analyze the phosphorylation status of multiple sites simultaneously, as demonstrated in studies examining Ser155, Ser181, Ser321, and Ser449 phosphorylation .

• Mutational analysis: Comparing the phosphorylation pattern of wild-type HDAC7 with site-specific serine-to-alanine mutants can reveal interdependencies between different phosphorylation sites .

• Phosphatase treatment coupled with site-specific detection: Controlled partial dephosphorylation followed by detection with site-specific antibodies can reveal the hierarchy and differential susceptibility of phosphorylation sites .

These approaches have revealed that phosphorylation of HDAC7 can be hierarchical, with some sites depending on the phosphorylation status of others .

How can researchers study the HDAC7 phosphorylation-dephosphorylation cycle in experimental systems?

To investigate the complete phosphorylation-dephosphorylation cycle of HDAC7:

• RNAi-mediated knockdown: Depleting specific kinases (e.g., PKD1) or phosphatases (e.g., PP2A-Cα and PP2A-Cβ) using siRNA can reveal their contributions to HDAC7 phosphorylation dynamics . For example, combined siRNA against PP2A-Cα and PP2A-Cβ has been shown to increase HDAC7 phosphorylation and promote its cytoplasmic localization .

• Pharmacological inhibitors: Specific inhibitors of kinases or phosphatases (e.g., okadaic acid for PP2A) can be used to acutely perturb the phosphorylation-dephosphorylation balance .

• In vitro dephosphorylation assays: Immunoprecipitated phosphorylated HDAC7 can be incubated with purified phosphatases (e.g., PP2A) to directly assess dephosphorylation kinetics .

• 14-3-3 competition assays: The R18 peptide, which disrupts 14-3-3 interactions, can be used to study how 14-3-3 binding protects phosphorylated HDAC7 from dephosphorylation .

• Metabolic labeling: [32P]-orthophosphate labeling combined with immunoprecipitation and phosphopeptide analysis provides a comprehensive view of the phosphorylation status across multiple sites .

These approaches collectively provide insights into the complex regulatory mechanisms controlling HDAC7 phosphorylation status in different cellular contexts .

Troubleshooting and Experimental Optimization

When using Phospho-HDAC7 (Ser155) antibodies, the following controls are critical:

• Phosphatase-treated samples: Treating a portion of your sample with lambda phosphatase will eliminate the phosphorylation signal, confirming antibody specificity for the phosphorylated form .

• Unstimulated vs. stimulated conditions: Including samples from both conditions provides a biological control, as stimulation with PMA or TCR activation should increase Ser155 phosphorylation .

• Phospho-deficient mutant: If possible, include an S155A HDAC7 mutant as a negative control for antibody specificity .

• Total HDAC7 antibody blotting: Always probe parallel samples with an antibody recognizing total HDAC7 regardless of phosphorylation status to normalize for protein expression levels .

• Loading controls: Include standard loading controls (e.g., GAPDH, β-actin) to ensure equal loading across lanes .

• Peptide competition: Pre-incubating the antibody with the phosphopeptide immunogen should abolish specific binding .

These controls help distinguish true phosphorylation signals from artifacts and enable accurate interpretation of experimental results .

How does sample preparation affect the detection of phosphorylated HDAC7?

Sample preparation is critical for reliable detection of phosphorylated HDAC7:

• Lysis buffer composition: Use buffers containing phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate) to prevent dephosphorylation during extraction .

• Temperature control: Keep samples cold throughout preparation to minimize phosphatase activity .

• Timing: Process samples quickly to preserve labile phosphorylation modifications .

• Detergent selection: For membrane proteins or nuclear extractions, the choice of detergent can affect extraction efficiency and preservation of phosphorylation .

• Denaturing conditions: SDS-PAGE sample buffers should contain sufficient SDS and reducing agents to fully denature proteins, exposing phosphorylation sites for antibody recognition .

• Sample handling: Avoid repeated freeze-thaw cycles of lysates, as this can activate endogenous phosphatases and proteases .

For optimal results in phosphorylation-specific Western blots, fresh samples typically yield the strongest and most consistent signals . When analyzing multiple phosphorylation sites, it may be necessary to optimize extraction conditions separately for each site, as their accessibility and stability may differ .